title: What's new in renal and pancreatic transplantation in 2011?
abstract: At the 11th meeting of the SFT Congress in Montpellier, several presentations were devoted to humoral rejection of kidney transplants, new immunosuppressive drugs, cancer after transplantation, and second pancreas transplantations. The main information drawn from these papers is summarized in this brief review.
authors.affiliation: Service of Nephrology, Dialysis and Transplantation, Centre Hospitalier Universitaire, Liège, Belgium. L.Weekers@chu.ulg.ac.be
authors.forename: L
authors.initials: L
authors.lastname: Weekers
mesh_terms: D006084:Graft Rejection / Q000276:immunology / Q000517:prevention & control; D006085:Graft Survival / Q000187:drug effects; D006801:Humans; D056724:Immunity, Humoral / Q000187:drug effects; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016030:Kidney Transplantation / Q000009:adverse effects / Q000276:immunology / Q000639:trends*; D016035:Pancreas Transplantation / Q000009:adverse effects / Q000639:trends*; D012086:Reoperation
chemical_list: D007166:Immunosuppressive Agents